Effects of informant replacement in Alzheimer's disease clinical trials

Abstract INTRODUCTION Alzheimer's disease (AD) trials require enrollment with an informant. METHODS We assessed relationships between informant replacement and Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS‐ADL) scores across four AD trials. Using generalized estima...

Full description

Bibliographic Details
Main Authors: Mikaela K. Nishida, Michelle M. Nuño, Joshua D. Grill, Daniel L. Gillen
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Online Access:https://doi.org/10.1002/trc2.12439